Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Reprod Immunol. 2015 Apr 22;110:14–21. doi: 10.1016/j.jri.2015.03.007

Table 1.

Baseline demographic and clinical characteristics

Variables Overall Injectable-HCs users Non-HCs users P-value
N 128 64 64

Age (years) 28 (23–36) 28 (23–36) 29 (23–37) 0.653
Marital status [% (n)]
 Single 2.4% (3) 0.0% (0) 4.7% (3) 0.057
 Stable partner 34.7% (44) 41.3% (26) 28.1% (18)
 Married 3.9% (5) 6.4% (4) 1.6% (1)
 Many partners 59.1% (75) 52.4% (33) 65.6% (42)
Sex work [% (n)] 79.7% (102) 79.7% (51) 79.7% (51) 1.000
Education [% (n)]
 <Grade 8 21.9% (28) 21.9% (14) 21.9% (14) 0.972
 Grade 8–10 29.7% (38) 28.1% (18) 31.3% (20)
 Grade 11–12 48.4% (62) 50.0% (32) 46.9% (30)
Condom use [% (n)]
Always use condom with steady partner(s) 25.0% (32) 20.3% (13) 29.7% (19) 0.308
Always use condom with casual partner(s) 53.9% (69) 46.9% (30) 60.9% (39) 0.156
Condom use at last sex act 59.4% (76) 53.1% (34) 65.6% (42) 0.208
Positive test or culture result [% (n)]
 Genital discharge 17.2% (22) 12.5% (8) 21.9% (14) 0.241
 Bacterial vaginosis (Nugent >7) 51.2% (65) 50.8% (32) 51.6% (33) 1.000
Trichomonas vaginalis 18.9% (24) 19.1% (12) 18.8% (12) 1.000
Chlamydia trachomatis 6.3% (8) 4.8% (3) 7.8% (5) 0.718
Neisseria gonorrhoeae 6.3% (8) 1.6% (1) 10.9% (7) 0.062
Mycoplasma genitalium 1.6% (2) 3.2% (2) 0.0% (0) 0.244
 HSV-2 PCR 2.4% (3) 3.2% (2) 1.6% (1) 1.000
*

Descriptive statistics are reported as percentages (categorical data) or medians and IQRs (continuous data).